SERUM AKT2 LEVELS AS A MARKER FOR LUNG CANCER


Karaman S., Erturk K., Serilmez M. , Duranyilidiz D., Oral E. N. , Dagoglu N.

ACTA MEDICA MEDITERRANEA, cilt.35, ss.3269-3272, 2019 (SCI İndekslerine Giren Dergi) identifier identifier

  • Cilt numarası: 35 Konu: 6
  • Basım Tarihi: 2019
  • Doi Numarası: 10.19193/0393-6384_2019_6_514
  • Dergi Adı: ACTA MEDICA MEDITERRANEA
  • Sayfa Sayıları: ss.3269-3272

Özet

Introduction: AKT overexpression has shown in some cancer types such as breast, prostate, ovarian and gastric cancer (1, 2, 3). Due to conflicting results reported in recent studies investigating the phosphoinositide-3-kinase-protein kinase (PI3K) signal transduction pathway and lung cancer, we know AKT2 plays a critical role (4). The aim of our study is to investigate whether circulating AKT2 levels have diagnostic, predictive and prognostic role in lung cancer.